180 related articles for article (PubMed ID: 7942840)
1. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.
Tambor ES; Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Holtzman NA
Am J Hum Genet; 1994 Oct; 55(4):626-37. PubMed ID: 7942840
[TBL] [Abstract][Full Text] [Related]
2. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
[TBL] [Abstract][Full Text] [Related]
3. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
[TBL] [Abstract][Full Text] [Related]
4. Educating patients about cystic fibrosis carrier screening in a primary care setting.
Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Tambor ES; Holtzman NA
Arch Fam Med; 1996 Jun; 5(6):336-40. PubMed ID: 8640323
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis carrier population screening in the primary care setting.
Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
[TBL] [Abstract][Full Text] [Related]
7. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
[TBL] [Abstract][Full Text] [Related]
8. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
Henneman L; Bramsen I; Van Os TA; Reuling IE; Heyerman HG; van der Laag J; van der Ploeg HM; ten Kate LP
Prenat Diagn; 2001 Jan; 21(1):1-9. PubMed ID: 11180232
[TBL] [Abstract][Full Text] [Related]
9. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.
Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
Am J Hum Genet; 1996 Mar; 58(3):617-27. PubMed ID: 8644721
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a cystic fibrosis carrier testing clinic for couples.
Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
[TBL] [Abstract][Full Text] [Related]
11. Population screening for cystic fibrosis in Western Australia: community response.
Honnor M; Zubrick SR; Walpole I; Bower C; Goldblatt J
Am J Med Genet; 2000 Jul; 93(3):198-204. PubMed ID: 10925381
[TBL] [Abstract][Full Text] [Related]
12. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
[TBL] [Abstract][Full Text] [Related]
13. Involving consumers in the development of an educational program for cystic fibrosis carrier screening.
Myers MF; Bernhardt BA; Tambor ES; Holtzman NA
Am J Hum Genet; 1994 Apr; 54(4):719-26. PubMed ID: 8128971
[TBL] [Abstract][Full Text] [Related]
14. CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by "non-carrier" couples.
Callanan NP; Cheuvront BJ; Sorenson JR
Genet Med; 1999; 1(7):323-7. PubMed ID: 11263543
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of preconceptional and prenatal cystic fibrosis carrier screening: a systematic review.
Banzi R; Allocati E; Gerardi C; Castellani C; Rissone M; Stracuzzi M; Ferrario L; Foglia E; Mosconi P; Colombo C
Epidemiol Prev; 2023; 47(4-5):243-256. PubMed ID: 37846447
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
[TBL] [Abstract][Full Text] [Related]
17. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.
McClaren BJ; Metcalfe SA; Aitken M; Massie RJ; Ukoumunne OC; Amor DJ
Eur J Hum Genet; 2010 Oct; 18(10):1084-9. PubMed ID: 20512163
[TBL] [Abstract][Full Text] [Related]
18. Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
Gordon C; Walpole I; Zubrick SR; Bower C
Am J Med Genet A; 2003 Jul; 120A(2):199-208. PubMed ID: 12833400
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing medical practitioner participation in population carrier screening for cystic fibrosis.
Valente GM; Amor DJ; Ioannou LJ; Archibald AD
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):232-238. PubMed ID: 33135161
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
Maxwell SJ; Kyne G; Molster C; Barker NM; Ormsby J; O'Leary P
Genet Test Mol Biomarkers; 2011 Mar; 15(3):159-64. PubMed ID: 21204697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
